Literature DB >> 17651428

Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression.

Jun Zhu1, Michael T Bardo, Ronald C Bruntz, Dustin J Stairs, Linda P Dwoskin.   

Abstract

Previous research has shown that individual differences in response to novelty predict self-administration and the locomotor response to psychostimulant drugs of abuse. The aim of the present study was to determine if individual differences in response to novelty based on inescapable or free-choice novelty tests predict dopamine transporter (DAT) function and trafficking as well as nicotine-induced modulation of DAT. Results show that the maximal velocity (Vmax) of [3H]dopamine uptake into prefrontal cortex (PFC) synaptosomes correlated negatively with the locomotor response to inescapable novelty. In contrast, Vmax correlated positively with novelty place preference in the free-choice novelty test. The divergent correlations between DAT and the two behavioral phenotypes suggest a differential contribution of DAT in these phenotypes, which are known not to be isomorphic. Furthermore, rats categorized as high responders to inescapable novelty had lower Vmax values, which were accompanied by less DAT expression at the cell surface in PFC compared with low responders, suggesting that inherent individual differences in DAT cellular localization may underlie the differential response to novelty. Compared with the saline control, nicotine increased Vmax and cell surface DAT immunoreactivity in PFC from high responders but not from low responders. Similarly, nicotine increased Vmax and cell surface DAT in PFC in rats classified as low in novelty place preference but not in rats classified as high in novelty place preference. Thus, despite the different behavioral phenotypes, the pharmacological effect of nicotine to increase DAT function and cell surface expression was apparent, such that rats with inherently lower DAT function show a greater sensitivity to the neurochemical effect of nicotine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651428     DOI: 10.1111/j.1460-9568.2007.05690.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  Aging in rhesus macaques is associated with changes in novelty preference and altered saccade dynamics.

Authors:  Nathan Insel; María Luisa Ruiz-Luna; Michelle Permenter; Julie Vogt; Cynthia A Erickson; Carol A Barnes
Journal:  Behav Neurosci       Date:  2008-12       Impact factor: 1.912

2.  The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.

Authors:  Jared W Young; Andrew K L Goey; Arpi Minassian; William Perry; Martin P Paulus; Mark A Geyer
Journal:  Pharmacol Biochem Behav       Date:  2010-04-02       Impact factor: 3.533

3.  Adolescent social defeat alters markers of adult dopaminergic function.

Authors:  Andrew M Novick; Gina L Forster; Shanaz M Tejani-Butt; Michael J Watt
Journal:  Brain Res Bull       Date:  2011-06-30       Impact factor: 4.077

4.  Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.

Authors:  Thomas E Wooters; Michael T Bardo; Linda P Dwoskin; Narasimha M Midde; Adrian M Gomez; Charles F Mactutus; Rosemarie M Booze; Jun Zhu
Journal:  Behav Brain Res       Date:  2011-01-08       Impact factor: 3.332

5.  The contribution of the central nucleus of the amygdala to individual differences in amphetamine-induced hyperactivity.

Authors:  Mary E Cain; Rosemary A Coolon; Margaret J Gill
Journal:  Behav Brain Res       Date:  2009-03-19       Impact factor: 3.332

6.  Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Authors:  L M Moran; R M Booze; K M Webb; C F Mactutus
Journal:  Exp Neurol       Date:  2012-10-11       Impact factor: 5.330

7.  Effect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuse.

Authors:  María-Julia García-Fuster; Sarah M Clinton; Stanley J Watson; Huda Akil
Journal:  Neuropsychopharmacology       Date:  2008-06-25       Impact factor: 7.853

8.  HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.

Authors:  Jun Zhu; Charles F Mactutus; David R Wallace; Rosemarie M Booze
Journal:  J Pharmacol Exp Ther       Date:  2009-03-26       Impact factor: 4.030

Review 9.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

10.  Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.

Authors:  Landhing M Moran; Sylvia Fitting; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2014-10-05       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.